NOVOCURE LTD (NVCR)

JE00BYSS4X48 - Common Stock

12.74  +0.5 (+4.08%)

Premarket: 13.2998 +0.56 (+4.39%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
509.34M537.80M535.00M494.40M351.30M
Cost Of Goods
128.28M114.90M114.90M106.50M88.60M
Gross Profit
381.06M423.00M420.20M387.90M262.70M
Operating Expenses
613.93M512.50M464.50M357.50M263.60M
Research and Development
223.06M206.10M201.30M132.00M79.00M
Selling, General, and Administrative Expenses
390.87M306.40M263.20M225.50M184.60M
Operating Income
-232.87M-89.50M-44.30M30.40M-900.00K
Interest Income/Expense
15.46M3.50M-7.30M-13.20M-9.90M
Other Income/Expense
25.66M4.10M-500.00K900.00K2.00M
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-191.74M-81.80M-52.10M18.10M-8.80M
Income Tax
15.30M10.70M6.30M9.60M-1.60M
Net Income
-207.04M-92.50M-58.40M19.80M-7.20M
EBITDA
-221.90M-78.88M-34.05M39.55M7.56M
 
Per Share Data
EPS Diluted Total Ops
-1.95-0.88-0.560.18-0.07
Non GAAP EPS
-1.95-0.88-0.560.19-0.08
 
Statistics
Gross Profit Margin
74.81%78.65%78.54%78.46%74.78%
Profit Margin
-40.65%-17.20%-10.92%4.00%-2.05%
Operating Profit Margin
-45.72%-16.64%-8.28%6.15%-0.26%

All data in USD

Charts